These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30256435)

  • 1. Nonlinear model with random inflection points for modeling neurodegenerative disease progression.
    Sun M; Wang Y
    Stat Med; 2018 Dec; 37(30):4721-4742. PubMed ID: 30256435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging nonlinear dynamic models to predict progression of neuroimaging biomarkers.
    Sun M; Zeng D; Wang Y
    Biometrics; 2019 Dec; 75(4):1240-1252. PubMed ID: 31264711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penalized nonlinear mixed effects model to identify biomarkers that predict disease progression.
    Chen H; Zeng D; Wang Y
    Biometrics; 2017 Dec; 73(4):1343-1354. PubMed ID: 28182831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating disease onset from change points of markers measured with error.
    Lee U; Carroll RJ; Marder K; Wang Y; Garcia TP
    Biostatistics; 2021 Oct; 22(4):819-835. PubMed ID: 31999331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructing disease onset signatures using multi-dimensional network-structured biomarkers.
    Li X; Zeng D; Marder K; Wang Y
    Biostatistics; 2020 Jan; 21(1):122-138. PubMed ID: 30084874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EARLY DIAGNOSIS OF NEUROLOGICAL DISEASE USING PEAK DEGENERATION AGES OF MULTIPLE BIOMARKERS.
    Gao F; Wang Y; Zeng D;
    Ann Appl Stat; 2019; 13(2):1295-1318. PubMed ID: 31673303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging plus X: multimodal models of neurodegenerative disease.
    Oxtoby NP; Alexander DC;
    Curr Opin Neurol; 2017 Aug; 30(4):371-379. PubMed ID: 28520598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Prediction of Motor Diagnosis in Huntington's Disease Using a Joint Modeling Approach.
    Li K; Furr-Stimming E; Paulsen JS; Luo S;
    J Huntingtons Dis; 2017; 6(2):127-137. PubMed ID: 28582868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of biomarkers for Huntington's disease.
    Weir DW; Sturrock A; Leavitt BR
    Lancet Neurol; 2011 Jun; 10(6):573-90. PubMed ID: 21601164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological markers of cognition in prodromal Huntington's disease: a review.
    Papp KV; Kaplan RF; Snyder PJ
    Brain Cogn; 2011 Nov; 77(2):280-91. PubMed ID: 21889251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of inter-scanner and within-subject variance in structural MRI based automated diagnosing.
    Kostro D; Abdulkadir A; Durr A; Roos R; Leavitt BR; Johnson H; Cash D; Tabrizi SJ; Scahill RI; Ronneberger O; Klöppel S;
    Neuroimage; 2014 Sep; 98():405-15. PubMed ID: 24791746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington disease: natural history, biomarkers and prospects for therapeutics.
    Ross CA; Aylward EH; Wild EJ; Langbehn DR; Long JD; Warner JH; Scahill RI; Leavitt BR; Stout JC; Paulsen JS; Reilmann R; Unschuld PG; Wexler A; Margolis RL; Tabrizi SJ
    Nat Rev Neurol; 2014 Apr; 10(4):204-16. PubMed ID: 24614516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical Approaches to Longitudinal Data Analysis in Neurodegenerative Diseases: Huntington's Disease as a Model.
    Garcia TP; Marder K
    Curr Neurol Neurosci Rep; 2017 Feb; 17(2):14. PubMed ID: 28229396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging as a tool to study the sources of phenotypic heterogeneity in Huntington's disease.
    Garcia-Gorro C; Camara E; de Diego-Balaguer R
    Curr Opin Neurol; 2017 Aug; 30(4):398-404. PubMed ID: 28509681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple kernel learning with random effects for predicting longitudinal outcomes and data integration.
    Chen T; Zeng D; Wang Y
    Biometrics; 2015 Dec; 71(4):918-28. PubMed ID: 26177419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington's disease.
    Long JD; Mills JA
    BMC Med Res Methodol; 2018 Nov; 18(1):138. PubMed ID: 30445915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
    Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
    BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.
    Tippett LJ; Waldvogel HJ; Snell RG; Vonsattel JP; Young AB; Faull RLM
    Adv Neurobiol; 2017; 15():129-161. PubMed ID: 28674980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI-Application in Premanifest Huntington's Disease.
    Wu D; Faria AV; Younes L; Ross CA; Mori S; Miller MI
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.